Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. - Wikidata - wikimedia - TriplyDB

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

http://www.wikidata.org/entity/Q34137756

about

Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic mice Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice Increased response to cholesterol feeding in apolipoprotein C1-deficient mice Lipidomics reveals multiple pathway effects of a multi-components preparation on lipid biochemistry in ApoE*3Leiden.CETP mice ApoE plasma levels and risk of cardiovascular mortality in old age Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein E-deficient mice Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients.Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin.Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.The effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice.Lipid metabolism in long-lived families: the Leiden Longevity Study Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited.A practical approach to using mice in atherosclerosis research.Animal models of atherosclerosis.Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice.Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice.The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.Classification for Longevity Potential: The Use of Novel Biomarkers Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease.Pharmacotherapy of coronary atherosclerosis.Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation.Most appropriate animal models to study the efficacy of statins: a systematic review.Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease.Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease.Deletion of P2Y2 receptor reveals a role for lymphotoxin-α in fatty streak formation.Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion.Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development.Evaluation of antiatherosclerotic drugs by Raman spectroscopy.Atherosclerosis and the mouse: a decade of experience.

P2860

Q27344569-503F1C4E-20AF-403F-8FBB-6D9F8F3F813A Q28070313-E6533C32-53EB-424D-A134-8E261AEF494B Q28222098-04244718-3419-4D5E-95EA-D525910A55AC Q28513259-4DEBEB45-A306-4FE6-B4BE-44419CE15F47 Q28587768-C2FD24B2-C75D-4DED-9515-251223FC39DC Q28732458-5264E60B-D515-457A-9592-A89ACADC429E Q33242076-C405C677-8976-411F-9D44-8BF74AE212E3 Q33493427-6F5806A8-2A2A-45BA-BF23-1035CEBB0510 Q33775709-273D6549-E9E6-4723-B7E7-69C917517BD4 Q33905765-A4AD509F-267F-47F6-91B7-EC16AF552571 Q33937727-F351E6D5-60A0-4A82-BDB8-C413836E4ECE Q34065835-20D8F4F1-C8E4-4E94-9CDB-A7E7546BC093 Q34238694-51014F8B-D34D-41F1-BAF6-34A745CB5C8C Q34466387-AB2E1C06-FC65-49FF-AB2E-079043D1EBE7 Q34469947-4142D02B-C3E3-4806-B309-AF755758648A Q34672078-3B019E93-68EF-4429-856D-05BC26671072 Q35058473-95C0EA50-6348-4DAD-A2D5-541B69F4F152 Q35080214-2278104B-BFC0-4FD7-B4FB-59CBD127EDD8 Q35347421-B15E6BAA-9DD4-4362-AFBE-0E0C17048B86 Q35754358-2ECA76DE-C7CA-4E92-9197-DFCB3765B5A8 Q35903298-040A769D-F442-498B-B6F8-9353E28DC324 Q36130584-897D5693-0E28-4C69-AC1D-A2B1552004CC Q37113551-30CA81DA-8B0D-47E4-8664-62AC2D776641 Q37230691-F8699C92-6368-4424-A9AD-A780330ABD59 Q37352384-32D40818-5642-45B1-B4DF-2C336F1F4504 Q37361432-00640CB8-C628-4E90-93C5-F81F8C613F9A Q37373417-80F58F13-8E52-4548-86F8-598C5C79C3C0 Q37417026-F042A28F-0298-440E-8241-FF9E510F8AB4 Q37519710-32F09A20-8286-460A-8A40-A5244210D8E7 Q37683992-A406C675-0AAA-494A-8094-73A279E9E2BA Q38077675-28D3272D-66F2-4A73-8E02-8CAFDEB0C155 Q38234426-6B66CE1C-1097-48DA-8DB7-BEED4AD12065 Q38781034-1C9109AB-05F9-42E0-992F-E3C65F48873F Q39224276-1A147F7C-F3D3-416B-BCC6-D6CE25906AA4 Q39645825-5A006DB3-0937-4656-A277-4C24D846A6B9 Q39741648-D7B9CDB8-77D4-48F7-88C6-9738E9DB361D Q39961306-C0583EC2-2AF3-410B-BE45-990A42B75C20 Q41073067-7AC52044-B60A-4733-84D4-64E3E435C03B Q41108475-EC3BF5A8-1CB5-4796-BCF5-5ABA27DFBFA8 Q41548189-C0C2C002-408C-49E0-9303-FB1F6B0190B5

P2860

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

http://www.wikidata.org/entity/Q34137756

description

1994 nî lūn-bûn

@nan

1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.

@ast

Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.

@en

Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.

@nl

type

label

Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.

@ast

Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.

@en

Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.

@nl

prefLabel

Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.

@ast

Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.

@en

Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.

@nl

P1433

Q34137756-2A435DC2-DA1B-459B-8DD8-89E0471BA9ED

P1476

Q34137756-07657CFC-DC10-4D6C-BE8F-B581AD6BCA37

P2093

Q34137756-3C77A519-B514-4F80-9028-593CA57084DD

Q34137756-493CE7EC-0196-4A91-96F1-D6ABCEC9EB59

Q34137756-6D341641-4DE4-4E4E-A532-A6086537D81C

Q34137756-73C88712-222D-48E7-A4A6-0CFB14B953E2

Q34137756-785B2A0C-C387-4033-ACA0-1EB1326D3495

Q34137756-7E471E70-BD3C-4D79-92A4-5F53036E1C4D

Q34137756-B604DF0F-1B3B-4D2D-BC59-1F5CBD362FE5

Q34137756-F5ED3DAE-5897-455A-9FD1-F54B5134ED88

P2860

Q34137756-0D3B1F75-F313-436C-9920-AED9FCAD4B0C

Q34137756-134C9BEF-7A2E-4D4B-AC76-2F59C606D55E

Q34137756-20F4A408-9975-4FD5-9553-7DF0931634D8

Q34137756-340439D1-77BD-4C6A-8B68-9E449779899D

Q34137756-3CD45392-B906-4D0D-BC6E-869B5A442E6F

Q34137756-4012218A-6D8B-4649-9D3B-9E20CB1CF608

Q34137756-415E1DFE-E4B1-4138-8883-745CED265667

Q34137756-5127770B-624A-4B92-AC07-74CD4BA067F9

Q34137756-55EAF540-C73A-45AB-BB9E-AA79FCE6C344

Q34137756-5B0E9A93-718A-464A-9A37-08934A022406

P304

Q34137756-CB2E81E4-EAD5-4ECB-BC5F-B232C90147EC

P31

Q34137756-BA258951-869F-4ACB-AF34-D38EEFE0AF24

P356

Q34137756-27D3368E-21CF-46FB-9A2F-3D50BFCE79B3

P407

Q34137756-822B1038-6B7D-4417-9E08-FCD53E163205

P433

Q34137756-F517B5F6-9350-4950-BC6A-7AC5F84D6785

P478

Q34137756-8DAC6769-FAE5-4C6C-8CDD-6CABA3B511DA

P577

Q34137756-D0EBC672-8704-442C-83AB-EB5C404DB7BE

P698

Q34137756-1E1EA010-3EED-45AD-8AA8-AE4BAF5A8996

P921

Q34137756-564A875F-2FAD-4747-8C9C-9567EAB69DE9

P932

Q34137756-526C6902-688E-499F-844A-A7E4FF9537A3

P356

P1433

Journal of Clinical Investigation

P1476

Diet-induced hyperlipoproteine ...... ein E3-Leiden transgenic mice.

@en

P2093

Frants RR

http://www.w3.org/2001/XMLSchema#string

Gijbels MJ

http://www.w3.org/2001/XMLSchema#string

Havekes LM

http://www.w3.org/2001/XMLSchema#string

Hofker MH

http://www.w3.org/2001/XMLSchema#string

HogenEsch H

http://www.w3.org/2001/XMLSchema#string

van Vlijmen BJ

http://www.w3.org/2001/XMLSchema#string

van den Maagdenberg AM

http://www.w3.org/2001/XMLSchema#string

van der Boom H

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree

Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits

Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences.

Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.

Quantitative assessment of atherosclerotic lesions in mice.

Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia.

Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia.

P304

1403-1410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI117117

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1994-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8163645

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

294153

http://www.w3.org/2001/XMLSchema#string